Physician profile
Simone Ferguson
NPI 1932606951
$3,253.09
in general payments reported to CMS, 2019-2025
10 companies · $359 in 2025
The $359 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $44.18 · 2023: $341 · 2024: $2,509 · 2025: $359.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,157 · Food and Beverage: $1,052.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,156.76 |
| Food and Beverage | $1,052.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec USA, INC. | $2,434.32 | 2024 | Iolmaster 700, Visumax, Cirrus Hd-Oct |
| Glaukos Corporation | $195.42 | 2025 | Istent Infinite, Idosetr |
| Oyster Point Pharma, INC. | $177.87 | 2023 | Tyrvaya |
| Apellis Pharmaceuticals, INC. | $124.98 | 2025 | Syfovre |
| Teva Pharmaceuticals USA, INC. | $122.45 | 2023 | Austedo |
| Tarsus Pharmaceuticals, INC. | $59.02 | 2024-2025 | Xdemvy |
| Alcon Vision LLC | $37.98 | 2023-2024 | Argos, Hydrus Microstent |
| Abbvie INC. | $24.89 | 2023 | |
| Johnson & Johnson Surgical Vision, INC. | $16.37 | 2024 | Tecnis Iol |
| Bausch & Lomb Americas INC. | $15.61 | 2024 | Vyzulta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Simone Ferguson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.